Regeneron Prevails over Amgen in Antitrust PCSK9 Lawsuit Protecting Biotech Innovation and Patient Access to Life-Saving Treatments

Litigation, Intellectual Property News

After a failed patent litigation campaign, they pivoted toward an anticompetitive bundling scheme that created a dangerous precedent that ...

Related articles